The combination of permanent iodine-125 seed implants and carmustine (BCNU) wafers is safe and effective in patients with recurrent glioblastoma multiforme (GBM), according to a report in the February issue of the Journal of Neurosurgery. Reuters Health Information
The investigational drug afatinib increases progression-free survival but not overall survival in refractory nonsmall-cell lung cancer (NSCLC) with epidermal growth-factor receptor mutation. Medscape Medical News
Concerned that Federal budget cuts will greatly affect cancer care, Dr. John Marshall challenges oncologists to be proactive and strive to reduce healthcare costs in their practices. Medscape Hematology-Oncology
Just as subtypes of breast carcinoma are now treated differently, it is likely that different ovarian carcinoma subtypes will best be treated with subtype-specific treatment protocols. Annals of Oncology
